Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-353
Closed -$17.3K 1231
2025
Q3
$17.3K Buy
353
+3
+0.9% +$154 0.01% 666
2025
Q2
$18.1K Sell
350
-17
-5% -$781 0.01% 594
2025
Q1
$17.2K Sell
367
-220
-37% -$11.4K 0.01% 604
2024
Q4
$30.1K Buy
587
+5
+0.9% +$259 0.01% 389
2024
Q3
$25.9K Buy
582
+5
+0.9% +$219 0.01% 502
2024
Q2
$23.2K Buy
577
+6
+1% +$227 0.01% 531
2024
Q1
$22.9K Buy
+571
New +$21.5K 0.01% 557

Other funds holding SNV

Rise Advisors's SNV Position: Q4 2025 in Review

Rise Advisors sold out of Synovus (SNV) in Q4 2025, closing a stake of 353 shares — an estimated $17.3K sold.

Rise Advisors first reported a position in SNV in Q1 2024 and held it in 7 quarters. The position peaked at $30.1K in Q4 2024. 452 funds tracked by Wall St. Rank hold SNV as of Q4 2025.

  • Rise Advisors reported no remaining Synovus position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 353 Synovus shares in Q4 2025, an estimated $17.3K.
  • Rise Advisors first reported a position in Synovus in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Synovus position peaked at $30.1K in Q4 2024.
  • 452 funds tracked by Wall St. Rank held Synovus as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.